Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl) pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide | Patent Publication Number 20180208596
US 20180208596 A1Patent NumberUS 10167291 B2
Application Number15707508
Filled DateSep 18, 2017
Priority DateJul 2, 2015
Publication DateJul 26, 2018
Original AssigneeAstrazeneca
Current AssigneeAcerta Pharma
Inventor/ApplicantsEdwin Aret
Tjeerd Barf
Jerry Evarts
Cecile Krejsa
Tim Ingallinera
Fritz Blatter
Tjeerd Barf
Jerry Evarts
Cecile Krejsa
Tim Ingallinera
Fritz Blatter
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.